Source: Journal of Hepatology. Conference titles: Annual Meeting of the European Association for the Study of the Liver. Unidade: FMRP
Assunto: HORMÔNIO DO CRESCIMENTO
ABNT
PITHON, R. M. et al. Iron chelating therapy decreases liver production of insulin-like growth factor (IGF)-I in polytransfused beta-thalassaemia patients. Journal of Hepatology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 27 ago. 2024. , 2006APA
Pithon, R. M., Milani, S. S., Ângulo, I. de L., Covas, D. T., Martinelli, A. L. C., & Martinelli, C. E. (2006). Iron chelating therapy decreases liver production of insulin-like growth factor (IGF)-I in polytransfused beta-thalassaemia patients. Journal of Hepatology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Pithon RM, Milani SS, Ângulo I de L, Covas DT, Martinelli ALC, Martinelli CE. Iron chelating therapy decreases liver production of insulin-like growth factor (IGF)-I in polytransfused beta-thalassaemia patients. Journal of Hepatology. 2006 ; 44( 2): S244.[citado 2024 ago. 27 ]Vancouver
Pithon RM, Milani SS, Ângulo I de L, Covas DT, Martinelli ALC, Martinelli CE. Iron chelating therapy decreases liver production of insulin-like growth factor (IGF)-I in polytransfused beta-thalassaemia patients. Journal of Hepatology. 2006 ; 44( 2): S244.[citado 2024 ago. 27 ]